fluconazole has been researched along with Diabetes Mellitus, Type 1 in 20 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with fluconazole, but not nystatin, reduced the production of phospholipase from C albicans oral isolates in patients with diabetes mellitus." | 2.70 | The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus. ( Bell, PM; Coulter, WA; Fulton, CR; Hayes, JR; Lamey, PJ; Willis, AM, 2001) |
| "Focal hepatosplenic candidiasis has been increasingly recognized as a variant of disseminated candidiasis in immunocompromised patients." | 2.40 | Candida splenic abscess in the absence of obvious immunodeficiency. ( Howden, CW; Kapur, A; Vasudeva, R, 1997) |
| "Although infective esophagitis is encountered sporadically in pediatric age group, but it should always be considered in high risk individuals and when conventional medication fails to resolve the symptoms." | 1.43 | Fungal Esophagitis in a Child with Insulin Dependent Diabetes Mellitus. ( Alsheikh, A; Assiri, A; Saeed, A; Zaidi, Z, 2016) |
| "Cryptococcosis is an opportunistic infection caused by Cryptococcus neoformans that typically presents in immunocompromised patients, most commonly in those with human immunodeficiency virus (HIV) infection." | 1.40 | Disseminated cryptococcosis in a diabetic patient. ( Khatu, S; Poojary, S, 2014) |
| "We treated a case of laryngeal Cryptococcus neoformans infection in a glucocorticosteroid-dependent patient with chronic obstructive pulmonary disease." | 1.29 | Laryngeal cryptococcus. Treatment with oral fluconazole. ( Greene, JN; Kerschner, JE; Ridley, MB, 1995) |
| "Cryptococcal meningitis was diagnosed in a 71-year-old male diabetic patient with underlying ischaemic heart disease, asthma and bilateral axillo-femoral vascular grafts." | 1.29 | Pyrolysis typing of isolates from a recurrence of systemic cryptococcosis. ( Hosein, IK; Magee, JT; Philpot, C; Yang, J, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 8 (40.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atabek, ME | 1 |
| Akyürek, N | 1 |
| Eklioglu, BS | 1 |
| Poojary, S | 1 |
| Khatu, S | 1 |
| Moskowitz, A | 1 |
| LeVarge, B | 1 |
| Burns, K | 1 |
| McSparron, JI | 1 |
| Minea, B | 1 |
| Nastasa, V | 1 |
| Kolecka, A | 1 |
| Mares, M | 2 |
| Marangoci, N | 1 |
| Rosca, I | 1 |
| Pinteala, M | 1 |
| Hancianu, M | 1 |
| Saeed, A | 1 |
| Assiri, A | 1 |
| Zaidi, Z | 1 |
| Alsheikh, A | 1 |
| Theodoropoulos, N | 1 |
| Angarone, M | 1 |
| El-Zaatari, MM | 1 |
| Hulten, K | 1 |
| Fares, Y | 1 |
| Baassiri, A | 1 |
| Balkis, M | 1 |
| Almashhrawi, A | 1 |
| El-Zaatari, FA | 1 |
| Thanka, J | 1 |
| Kuruvilla, S | 1 |
| Abraham, G | 1 |
| Shroff, S | 1 |
| Kumar, BA | 1 |
| Ranjitham, M | 1 |
| Tascini, C | 1 |
| Ferranti, S | 1 |
| Leonildi, A | 1 |
| Menichetti, F | 1 |
| Kerschner, JE | 1 |
| Ridley, MB | 1 |
| Greene, JN | 1 |
| Magee, JT | 1 |
| Philpot, C | 1 |
| Yang, J | 1 |
| Hosein, IK | 1 |
| Vorreuther, R | 1 |
| Kuss, M | 1 |
| Franzen, W | 1 |
| Engelking, R | 1 |
| Altenburg, A | 1 |
| Benedetti, E | 1 |
| Gruessner, AC | 1 |
| Troppmann, C | 1 |
| Papalois, BE | 1 |
| Sutherland, DE | 1 |
| Dunn, DL | 1 |
| Gruessner, RW | 1 |
| Kapur, A | 1 |
| Vasudeva, R | 1 |
| Howden, CW | 1 |
| Antony, SJ | 1 |
| Patel, A | 1 |
| Leonard, J | 1 |
| Kumar, A | 1 |
| Turney, JH | 1 |
| Willis, AM | 1 |
| Coulter, WA | 1 |
| Fulton, CR | 1 |
| Hayes, JR | 1 |
| Bell, PM | 1 |
| Lamey, PJ | 1 |
| Arredondo, G | 1 |
| Suárez, E | 1 |
| Calvo, R | 1 |
| Vazquez, JA | 1 |
| García-Sanchez, J | 1 |
| Martinez-Jordá, R | 1 |
| Gibb, AP | 1 |
| Aggarwal, R | 1 |
| Swainson, CP | 1 |
| Conti, DJ | 1 |
| Tolkoff-Rubin, NE | 1 |
| Baker, GP | 1 |
| Doran, M | 1 |
| Cosimi, AB | 1 |
| Delmonico, F | 1 |
| Auchincloss, H | 1 |
| Russell, PS | 1 |
| Rubin, RH | 1 |
1 review available for fluconazole and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Candida splenic abscess in the absence of obvious immunodeficiency.
Topics: Abscess; Antifungal Agents; Candidiasis; Diabetes Mellitus, Type 1; Drainage; Female; Fluconazole; G | 1997 |
1 trial available for fluconazole and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus.
Topics: Analysis of Variance; Antifungal Agents; Bacterial Adhesion; Candida albicans; Candidiasis, Oral; Ch | 2001 |
18 other studies available for fluconazole and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Frequency of vagınal candida colonization and relationship between metabolic parameters in children with type 1 diabetes mellitus.
Topics: Adolescent; Antifungal Agents; Blood Glucose; Candida; Candidiasis, Vulvovaginal; Carrier State; Chi | 2013 |
Disseminated cryptococcosis in a diabetic patient.
Topics: Administration, Oral; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Diabetes Mellitus, | 2014 |
A Cryptic Consolidation.
Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cough; Cryptococcosis; Cryptococcus n | 2015 |
Etiologic Agents and Antifungal Susceptibility of Oral Candidosis from Romanian patients with HIV-infection or type 1 diabetes mellitus.
Topics: Antifungal Agents; Candida; Candidiasis, Oral; Diabetes Complications; Diabetes Mellitus, Type 1; Dr | 2016 |
Fungal Esophagitis in a Child with Insulin Dependent Diabetes Mellitus.
Topics: Abdominal Pain; Antifungal Agents; Biopsy; Candida; Candidiasis; Child; Diabetes Mellitus, Type 1; E | 2016 |
Photo quiz. Lip lesion in a solid organ transplant recipient.
Topics: Amphotericin B; Antifungal Agents; Coccidioides; Coccidioidomycosis; Diabetes Mellitus, Type 1; Diab | 2012 |
Successful treatment of Candida albicans osteomyelitis of the spine with fluconazole and surgical debridement: case report.
Topics: Aged; Antifungal Agents; Candida albicans; Candidiasis; Debridement; Diabetes Mellitus, Type 1; DNA | 2002 |
Bilateral renal papillary necrosis due to Candida infection in a diabetic patient presenting as anuria.
Topics: Adult; Antifungal Agents; Anuria; Candidiasis; Diabetes Mellitus, Type 1; Fluconazole; Humans; Kidne | 2003 |
Breakthrough Fusarium sp probable pneumonia during fluconazole therapy in an AIDS patient with diabetes, candidemia, Pneumocystis carinii pneumonia and cytomegalovirus disseminated infection.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Cytomegalovirus Infections; D | 2006 |
Laryngeal cryptococcus. Treatment with oral fluconazole.
Topics: Administration, Oral; Antifungal Agents; Cryptococcosis; Diabetes Mellitus, Type 1; Fluconazole; Hum | 1995 |
Pyrolysis typing of isolates from a recurrence of systemic cryptococcosis.
Topics: Aged; Aneurysm; Asthma; Blood Vessel Prosthesis; Cryptococcosis; Cryptococcus neoformans; Diabetes M | 1994 |
[Gas-forming mycosis of the kidney].
Topics: Adult; Candidiasis; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Fluconazole; Humans; | 1993 |
Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome.
Topics: Adult; Age Factors; Amphotericin B; Antifungal Agents; Bacterial Infections; Candidiasis; Diabetes M | 1996 |
Use of fluconazole in the treatment of non-AIDS cryptococcal meningitis.
Topics: Aged; Antifungal Agents; Diabetes Mellitus, Type 1; Fluconazole; Humans; Male; Meningitis, Cryptococ | 1997 |
SLE, diabetes mellitus and emphysematous infections of the urinary tract.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Diabetes Mellitus, Type 1; Emphysema; Female; Fluc | 2000 |
Serum protein binding of itraconazole and fluconazole in patients with diabetes mellitus.
Topics: Adult; Antifungal Agents; Blood Proteins; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fatt | 1999 |
Successful treatment of Prototheca peritonitis complicating continuous ambulatory peritoneal dialysis.
Topics: Amphotericin B; Diabetes Mellitus, Type 1; Fluconazole; Flucytosine; Humans; Infections; Male; Middl | 1991 |
Successful treatment of invasive fungal infection with fluconazole in organ transplant recipients.
Topics: Adult; Candida; Cryptococcus neoformans; Diabetes Mellitus, Type 1; Female; Fluconazole; Humans; Kid | 1989 |